With the rise of cybersecurity threats from personal phones to computers, note-taking app Evernote bets its cloud platform can handle those issues.
“Part of our move to the public cloud was to really, really strengthen our already strong security, so that was a big step for us,” CEO Chris O'Neill told Cheddar. “The trust in security is really crucial because people trust their lives to Evernote.”
The company launched its Google Cloud Platform last February, moving 5 billion notes and 5 billion attachments to the cloud in 70 days. Evernote says that the new system encrypts user data at all times, offers improved disaster recovery planning, and will prove to be “faster and more reliable.”
The company’s platform supports 220 million subscribers, 83 percent of whom are international.
For full interview [click here](https://cheddar.com/videos/making-your-to-do-list-digital).
The Biden administration says it will impose inflation penalties on dozens of drug makers to lower costs for those on Medicare.
Two of the top low-cost online retailers are going head to head in a new legal battle. Cheddar News' Michelle Castillo breaks the lawsuit down.
The number of Americans filing for jobless benefits fell last week as the labor market continues to thrive despite high interest rates and elevated costs.
The earliest version of Disney's Mickey Mouse will become public domain on Jan. 1, 2024.
The toy magic oven called the Cookeez Makery is one of the hottest toys for kids this holiday season.
In the UK, IKEA is looking to give away some meatballs, and not just regular-size meatballs.
Dwayne 'The Rock' Johnson is set to star in a movie playing MMA and UFC legend, Mark Care, while Kevin Hart will headline a boxing project over on Peacock.
Coca-Cola is recalling drinks sold in three southern states due to possible "foreign materials" inside cans.
Stocks jumped after the Dow Jones closed at a record high while fresh retail sales data showed positive consumer spending ahead of the holidays.
The Food and Drug Administration is asking Congress for new powers, including the ability to mandate drug recalls and require eyedrop makers to undergo inspections before shipping products to the U.S.
